Genomics and epidemiology
Infectious diseases are continually evolving the means to escape treatment by antibiotics or vaccination. New emerging infections such as SARS CoV-2 and African swine fever are threatening the stability of the world economy in devastating ways. To assist the global responses to these issues, our experts use cutting-edge technologies such as sequencing and bioinformatics to understand the epidemiology of these diseases.
Understanding epidemiology enhances our ability to understand which control measures by public health are the most effective at suppressing the spread of infectious diseases.
The successful outcomes for treatment of infectious disease rely on rapid diagnostic tests necessary to accurately and sensitively detect pathogens in clinical samples. This requires the improvement of the technology being applied to the problem in an iterative way to ensure the assays remain appropriate for deployment in many settings, including diagnostic laboratories or in general practice in metropolitan or remote areas.
Novel Intervention Strategies
Antimicrobial resistant infections are predicted to be the most common cause of death in our hospitals in the next 30 years. We are also witnessing the emergence of novel infectious diseases, such as
SARS CoV-2, which require us to rapidly search for appropriate therapies to treat ill patients.
Our research leaders have an extensive global network of collaborators, ensuring we have the necessary links to make an impact around the world.